Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCQB - Delayed Quote USD

Northwest Biotherapeutics, Inc. (NWBO)

Compare
0.2000
+0.0050
+(2.56%)
At close: April 10 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,382
1,382
1,932
1,683
1,005
Operating Expense
67,890
67,890
57,440
68,864
53,707
Operating Income
-66,508
-66,508
-55,508
-67,181
-52,702
Net Non Operating Interest Income Expense
-7,767
-7,767
-5,241
-6,068
-5,011
Other Income Expense
-9,503
-9,503
-1,850
-31,783
236,839
Pretax Income
-83,778
-83,778
-62,599
-105,032
179,126
Net Income Common Stockholders
-85,192
-85,192
-64,373
-105,032
179,126
Diluted NI Available to Com Stockholders
-85,192
-85,192
-64,373
-105,032
179,126
Basic EPS
-0.07
-0.07
-0.06
-0.10
0.21
Diluted EPS
-0.07
-0.07
-0.06
-0.10
-0.06
Basic Average Shares
1,242,237
1,242,237
1,119,191
1,015,852
873,517
Diluted Average Shares
1,242,237
1,242,237
1,119,191
1,015,852
1,007,869
Total Operating Income as Reported
-66,508
-66,508
-55,508
-67,181
-52,702
Total Expenses
67,890
67,890
57,440
68,864
53,707
Net Income from Continuing & Discontinued Operation
-83,778
-83,778
-62,599
-105,032
179,126
Normalized Income
-75,094
-75,094
-60,827
-73,216
5,761.2200
Interest Expense
7,767
7,767
5,241
6,068
5,011
Net Interest Income
-7,767
-7,767
-5,241
-6,068
-5,011
EBIT
-76,011
-76,011
-57,358
-98,964
184,137
EBITDA
-73,967
-73,967
-55,625
-97,464
184,723
Reconciled Depreciation
2,044
2,044
1,733
1,500
586
Net Income from Continuing Operation Net Minority Interest
-83,778
-83,778
-62,599
-105,032
179,126
Total Unusual Items Excluding Goodwill
-8,684
-8,684
-1,772
-31,816
237,486
Total Unusual Items
-8,684
-8,684
-1,772
-31,816
237,486
Normalized EBITDA
-65,283
-65,283
-53,853
-65,648
-52,763
Tax Rate for Calcs
--
--
--
--
0.0003
Tax Effect of Unusual Items
--
--
--
--
64,121.2200
12/31/2021 - 12/14/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CVM CEL-SCI Corporation
0.2109
+7.06%
 
AVXL Anavex Life Sciences Corp.
8.54
-2.06%
 
ATNM Actinium Pharmaceuticals, Inc.
1.1500
-8.73%
 
ANVS Annovis Bio, Inc.
1.2800
-0.78%
 
MIST Milestone Pharmaceuticals Inc.
0.7500
+3.69%
 
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1490
0.00%
 
HEPA Hepion Pharmaceuticals, Inc.
0.4311
-11.62%
 
CYDY CytoDyn Inc.
0.2200
+4.76%
 
PSTV Plus Therapeutics, Inc.
0.7871
-6.28%
 
TNXP Tonix Pharmaceuticals Holding Corp.
17.30
-3.41%